InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Noyes Corinne. Director active across 1 company, notably Lyra Therapeutics, Inc.. Aggregated, 1 filings have been published. Activity tracked since 31 January 2023. The latest transaction was filed on 31 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration